Arginox Therapeutics - WI Milwaukee, Milwaukee 53226

Arginox Therapeutics entered the industry of Wholesale Pharmaceutical Products in 2001 and has grown to employ 1 to 4 people, generating an annual revenue of $100.000 to $499.999. The NAICS classifies this business under the code 424210, which describes it as a Wholesale Pharmaceutical Products. For further clarification, the SIC classifies this business under the code 5122 and described it as a Wholesale Pharmaceutical Products. The business provides service to the B2B market.

To acquire more information, please contact Steve Grant by calling No number given during business hours. You can also write to the business’ Single Location at 10437 West Innovation Drive # 317, Milwaukee, Wisconsin WI 53226. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .

Company: Arginox Therapeutics
Representative: Steve Grant
Place of Business: 10437 West Innovation Drive # 317, Milwaukee, WI 53226
Contact Number: No number given
Type of Service: Wholesale Pharmaceutical Products
SIC Number: 5122
NAICS Number: 424210
Locality: Single Location
Market Type: B2B (Business to Business)
Began: 2001
Income/Year: $100.000 to $499.999
Laborers: 1 to 4
Share This Company:

Arginox Therapeutics is a company operating from Milwaukee, Wisconsin providing professional Wholesale Pharmaceutical Products and relevant B2B variables. It was founded in 2001 and registered with the SIC code 5122 as Wholesale Pharmaceutical Products, and with the NAICS code 424210 as Wholesale Pharmaceutical Products.

With a current employee count of 1 to 4, Arginox Therapeutics has gone to report making $100.000 to $499.999 per annum on its journey towards growth. This company invites you to contact its representative Steve Grant at No number given for related queries, or to locate its Single Location using the coordinates .

The Single Location can also be found at the street address 10437 West Innovation Drive # 317 in Milwaukee, Wisconsin 53226 and can be engaged online through the company website at , the company Twitter , and Facebook page .